Temporal changes in haematocrit following artemisinin-based combination treatments of uncomplicated falciparum malaria in children
Open Access
- 26 October 2015
- journal article
- research article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 15 (1) , 1-14
Abstract
Artemisinin-based combination treatments (ACTs) or intravenous artesunate are used in over 100 countries for uncomplicated or severe falciparum malaria. Although intravenous artesunate may cause delayed haemolytic anaemia, there is little evaluation of the temporal changes in haematocrit following ACTs. Clinical and parasitological parameters were measured before and following treatment of uncomplicated falciparum malaria in children with artesunate-amodiaquine (AA) or artemether-lumefantrine (AL) over 6-weeks. Changes in haematocrit were characterized in individual patients based on a haematocrit -1asexual forms were significantly higher in children with ≥5 units compared to r = 0.55, P < 0.0001). Bland-Altman analysis of 9 or 10 multiples of anaemia half-time and anaemia recovery times showed narrow limit of agreement with insignificant biases (P = 0.19 or 0.63, respectively). In uncomplicated falciparum malaria, increases or falls in haematocrit are common following ACTs. Falls in haematocrit ≥ 5 units are common and may or may not result in early or late anaemia. In children who recovered from acute falciparum malaria-associated anaemia following ACTs, decline in haematocrit deficit is mono-exponential. Pan African Clinical Trial Registry PACTR201508001188143, 3 July 2015; PACTR201508001191898, 7 July 2015 http://www.pactr.org.Keywords
This publication has 40 references indexed in Scilit:
- A longitudinal study on anaemia in children with Plasmodium falciparuminfection in the Mount Cameroon region: prevalence, risk factors and perceptions by caregiversBMC Infectious Diseases, 2013
- Treatment outcome of intravenous artesunate in patients with severe malaria in the Netherlands and BelgiumMalaria Journal, 2012
- A Simple Dose Regimen of Artesunate and Amodiaquine Based on Arm Span- or Age Range for Childhood Falciparum Malaria: A Preliminary EvaluationJournal of Tropical Pediatrics, 2011
- Therapeutic Efficacy and Effects of Artemether-Lumefantrine and Artesunate-Amodiaquine Coformulated or Copackaged on Malaria-Associated Anemia in Children with Uncomplicated Plasmodium falciparum Malaria in Southwest NigeriaThe American Journal of Tropical Medicine and Hygiene, 2011
- Intravenous Artesunate for Severe Malaria in Travelers, EuropeEmerging Infectious Diseases, 2011
- Use of Area Under the Curve to Evaluate the Effects of Antimalarial Drugs on Malaria-Associated Anemia After TreatmentAmerican Journal of Therapeutics, 2011
- Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trialThe Lancet, 2010
- Chlorproguanil−Dapsone−Artesunate versus Artemether−Lumefantrine: A Randomized, Double-Blind Phase III Trial in African Children and Adolescents with Uncomplicated Plasmodium falciparum MalariaPLOS ONE, 2009
- Qinghaosu (Artemisinin): The Price of SuccessScience, 2008
- STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENTThe Lancet, 1986